Tuberous Sclerosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
289
|
55
|
0.100 |
None |
0.970 |
33 |
|
1990 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.963 |
27 |
|
1994 |
2019 |
Hyperkalemic Mineralocorticoid Resistance
|
disease |
|
Disease or Syndrome
|
22
|
3
|
0.100 |
None |
0.917 |
12 |
|
2001 |
2018 |
Pseudohypoaldosteronism, Type II
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
27
|
42
|
0.100 |
None |
0.900 |
10 |
|
2001 |
2017 |
Lymphangioleiomyomatosis
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
96
|
17
|
0.100 |
None |
1.000 |
10 |
|
2000 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.080 |
None |
1.000 |
8 |
|
1998 |
2019 |
Bartter Disease
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
47
|
8
|
0.170 |
None |
1.000 |
7 |
|
2001 |
2012 |
Epilepsy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
1215
|
339
|
0.060 |
None |
1.000 |
6 |
|
2010 |
2019 |
Hamartoma
|
disease |
Neoplasms
|
Neoplastic Process
|
91
|
8
|
0.050 |
None |
1.000 |
5 |
|
1994 |
2010 |
PSEUDOHYPOALDOSTERONISM, TYPE IID
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
13
|
29
|
0.050 |
None |
1.000 |
5 |
|
2014 |
2018 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.040 |
None |
1.000 |
4 |
|
2015 |
2019 |
Angiomyolipoma
|
disease |
Neoplasms
|
Neoplastic Process
|
53
|
1
|
0.040 |
None |
1.000 |
4 |
|
1998 |
2015 |
Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
2152
|
553
|
0.040 |
None |
1.000 |
4 |
|
1998 |
2017 |
Hypernatremia
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
59
|
3
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2017 |
Renal tubular disorder
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
64
|
5
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2018 |
Angiomyolipoma of kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
36
|
1
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.030 |
None |
0.333 |
3 |
|
2005 |
2015 |
Metabolic alkalosis
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
27
|
5
|
0.130 |
None |
1.000 |
3 |
|
2002 |
2019 |
Subependymal Giant Cell Astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
44
|
2
|
0.030 |
None |
1.000 |
3 |
|
2010 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.030 |
None |
0.333 |
3 |
|
2005 |
2015 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Hamartoma Syndrome, Multiple
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
270
|
139
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2005 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2017 |
Hyperactive behavior
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
1263
|
112
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |